(Q34401712)

1 August 2017

1 reference

title

Severe depression: is there a best approach? (English)

1 reference

1 August 2017

Sonawalla SB

1

1 reference

1 August 2017

Fava M

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

15

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

765-776

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200115100-00003

1 August 2017

exact match

0 references

cites work

Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum.

1 reference

12 December 2020

Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine

1 reference

12 December 2020

Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Collaborative Working Group on Clinical Trial Evaluations

1 reference

12 December 2020

Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.

1 reference

12 December 2020

Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report

1 reference

12 December 2020

The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations?

1 reference

12 December 2020

Do psychosocial factors influence outcome in severely depressed female psychiatric in-patients?

1 reference

12 December 2020

Definition and epidemiology of treatment-resistant depression

1 reference

12 December 2020

Monoamine dysfunction and the pathophysiology and treatment of depression.

1 reference

12 December 2020

Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis

1 reference

12 December 2020

Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia

1 reference

12 December 2020

Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

1 reference

12 December 2020

Controversies in the diagnosis and treatment of severe depression

1 reference

12 December 2020

Unrecognized physical illness prompting psychiatric admission: a prospective study

1 reference

12 December 2020

Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease

1 reference

12 December 2020

Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.

1 reference

12 December 2020

Psychomotor Change as a Feature of Depressive Disorders: An Historical Overview

1 reference

12 December 2020

Factors associated with 1-year outcome of major depression in the community.

1 reference

12 December 2020

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

12 December 2020

Changes in regional brain activity in major depression after successful treatment with antidepressant drugs.

1 reference

12 December 2020

Impaired lymphocyte function in depressive illness

1 reference

12 December 2020

Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy.

1 reference

12 December 2020

Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies

1 reference

12 December 2020

The pharmacologic profile of mirtazapine

1 reference

12 December 2020

National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

12 December 2020

Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression--a longitudinal evaluation.

1 reference

12 December 2020

Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia

1 reference

12 December 2020

Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study

1 reference

12 December 2020

Outcome definitions and predictors in depression.

1 reference

12 December 2020

Uptake inhibition of biogenic amines by newer antidepressant drugs: Relevance to the dopamine hypothesis of depression

1 reference

12 December 2020

Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.

1 reference

12 December 2020

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

An Inventory for Measuring Depression

1 reference

12 December 2020

Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study.

1 reference

12 December 2020

Recovery and major depression: factors associated with twelve-month outcome

1 reference

12 December 2020

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression

1 reference

12 December 2020

A functional anatomical study of unipolar depression.

1 reference

12 December 2020

Anxiety and depression in a community sample: the influence of comorbidity on social functioning.

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

12 December 2020

Algorithms for the treatment of subtypes of unipolar major depression

1 reference

12 December 2020

Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs

1 reference

12 December 2020

Regional cerebral blood flow in unipolar depression measured with Tc-99m-HMPAO single photon emission computed tomography: negative findings.

1 reference

12 December 2020

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

12 December 2020

Subjective side effects during electroconvulsive therapy.

1 reference

12 December 2020

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.

1 reference

12 December 2020

Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process

1 reference

12 December 2020

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

12 December 2020

Paroxetine in the treatment of melancholia and severe depression

1 reference

12 December 2020

A multicenter evaluation of bupropion versus placebo in hospitalized depressed patients.

1 reference

12 December 2020

Severity of depression and response to fluoxetine

1 reference

12 December 2020

Life events, social support and marital relationships in the outcome of severe depression

1 reference

12 December 2020

Natural killer cell activity in depressive illness: preliminary report

1 reference

12 December 2020

Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Optimal dose regimen for paroxetine

1 reference

12 December 2020

Major tranquillisers used as antidepressants. A review

1 reference

12 December 2020

Is severe depression a separate indication? ECNP Consensus Meeting September 20, 1996, Amsterdam. European College of Neuropsychopharmacology

1 reference

12 December 2020

Comparative validity of two measures of psychomotor function in patients with severe depression

1 reference

12 December 2020

Reduction of prefrontal cortex glucose metabolism common to three types of depression

1 reference

12 December 2020

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

1 reference

12 December 2020

Novel strategies for treatment-resistant depression

1 reference

12 December 2020

Does the duration of illness before treatment affect the time taken to recover on treatment in severely depressed women?

1 reference

12 December 2020

Quantitative rating of depressive states

1 reference

12 December 2020

Role of the dopaminergic system in depression

1 reference

12 December 2020

Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.

1 reference

12 December 2020

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.

1 reference

12 December 2020

Distinguishing psychotic and non-psychotic melancholia

1 reference

12 December 2020

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

12 December 2020

Severity of depression and response to cognitive behavior therapy

1 reference

12 December 2020

Full and Abbreviated Courses of Maintenance Electroconvulsive Therapy

1 reference

12 December 2020

Treatment of severe depression

1 reference

12 December 2020

Major depressive subtypes and treatment response.

1 reference

12 December 2020

Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder

1 reference

12 December 2020

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

12 December 2020

Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia

1 reference

12 December 2020

A study on the blunted natural killer cell activity in severely depressed patients

1 reference

12 December 2020

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

12 December 2020

Headache and electroconvulsive therapy

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

The enduring psychosocial consequences of mania and depression.

1 reference

12 December 2020

Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary report

1 reference

12 December 2020

A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.

1 reference

12 December 2020

Evaluation of brain perfusion with technetium-99m bicisate single-photon emission tomography in patients with depressive disorder before and after drug treatment.

1 reference

12 December 2020

The economic burden of depression in 1990.

1 reference

12 December 2020

10.2165/00023210-200115100-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1047956087

0 references

1 reference